Gender differences in murine pulmonary responses elicited by cellulose nanocrystals

Particle and Fibre Toxicology

Volumn 13, Issue 1, 2016, Pages

  Shvedova, Anna A ^a,b   Kisin, Elena R ^a   Yanamala, Naveena ^a   Farcas, Mariana T ^a   Menas, Autumn L ^a   Williams, Andrew ^c   Fournier, Philip M ^d   Reynolds, Jeffrey S ^a   Gutkin, Dmitriy W ^d   Star, Alexander ^d   Reiner, Richard S ^e   Halappanavar, Sabina ^c   Kagan, Valerian E ^d  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HEALTH CANADA   (Canada)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e FOREST PRODUCTS LABORATORY   (United States)

Author keywords

Cellulose; Gender differences; Inflammation; MRNA expression; Oxidative stress; Pulmonary toxicity

Indexed keywords

CELLULOSE; COLLAGEN; MESSENGER RNA; NANOCRYSTAL; TRANSFORMING GROWTH FACTOR BETA; AIR POLLUTANT; BIOLOGICAL MARKER; NANOPARTICLE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; GENE ONTOLOGY; INFLAMMATORY CELL; LONG TERM EXPOSURE; LUNG INJURY; LUNG TOXICITY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; SEX DIFFERENCE; SIGNAL TRANSDUCTION; ADVERSE EFFECTS; AIR POLLUTANT; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; CHEMISTRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECTS; EXPOSURE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GERMFREE ANIMAL; IMMUNOLOGY; LUNG; METABOLISM; PARTICLE SIZE; PATHOLOGY; RESPIRATORY MUCOSA; SCANNING ELECTRON MICROSCOPY; SEXUAL DEVELOPMENT; SURFACE PROPERTY; TOXICITY; ULTRASTRUCTURE;

AIR POLLUTANTS; ANIMALS; BIOMARKERS; CELLULOSE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INHALATION EXPOSURE; LUNG; MALE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA; RNA, MESSENGER; SEX CHARACTERISTICS; SPECIFIC PATHOGEN-FREE ORGANISMS; SURFACE PROPERTIES;

EID: 84975702010     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/s12989-016-0140-x     Document Type: Article

References (110)

1. Moon RJ, Martini A, Nairn J, Simonsen J, Youngblood J. Cellulose nanomaterials review: structure, properties and nanocomposites. Chem Soc Rev. 2011;40(7):3941-94. doi: 10.1039/c0cs00108b.
2. Postek MT, Moon RJ, Rudie A, Bilodeau M. Production and Applications of Cellulose Nanomaterials. Peachtree Corners, GA: TAPPI; 2013.
3. Floros M, Hojabri L, Abraham E, Jose J, Thomas S, Pothan L, et al. Enhancement of thermal stability, strength and extensibility of lipid-based polyurethanes with cellulose-based nanofibers. Polym Degrad Stab. 2012;97(10):1970-8. http://dx.doi.org/10.1016/j.polymdegradstab.2012.02.016.
4. H.P.S.A. K, A.H. B, A.F.I. Y. Green composites from sustainable cellulose nanofibrils: a review. Carbohyd Polym. 2012;87:963-79.
5. Siqueira G, Bras J, Dufresne A. Cellulosic bionanocomposites: a review of preparation, properties and applications. Polym. 2010;2:728-65.
6. Davis JMG. The need for standardising testing procedures for all products capable of liberating respirable fibres: the example of materials based on cellulose. Br J Ind Med. 1993;50:187-90.
7. Milton DK, Godleski JJ, Feldman HA, Greaves IA. Toxicity of intratracheally instilled cotton dust, cellulose, and endotoxin. Am Rev Respir Dis. 1990;142(1):184-92. doi: 10.1164/ajrccm/142.1.184.
8. Muhle H, Bellmann B. Untersuchungen der Beständigkeit von Zellulosefasern in der Rattenlunge. Hannover: Fraunhofer Institut für Toxikologie und Aerosolforschung; 1995.
9. Muhle H, Ernst H, Bellmann B. Investigation of the durability of cellulose fibres in rat lungs. Ann Occup Hyg. 1997;41(Supplement 1):184-8.
10. Tatrai E, Ungvary G. The aetiology of experimental fibrosing alveobronchiolitis induced in rats by paprika dust. Br J Ind Med. 1992;49(7):494-8.
11. Ericsson J, Jarvholm B, Norin F. Respiratory symptoms and lung function following exposure in workers exposed to soft paper tissue dust. Int Arch Occup Environ Health. 1988;60(5):341-5.
12. Jarvholm B, Thoren K, Brolin I, Ericsson J, Morgan U, Tylen U, et al. Lung function in workers exposed to soft paper dust. Am J Ind Med. 1988;14(4):457-64.
13. Thorén K, Järvholm B, Sällsten G, Thiringer G. Respiratory symptoms and asthma among workers exposed to paper dust: a cohort study. Am J Ind Med. 1994;26:489-96.
14. Thorén K, Sällsten G, Bake B, Drake U, Järvholm B, Sahle W. Lung function and respiratory symptoms among workers in a soft paper mill. Int Arch Occup Environ Health. 1989;61:467-71.
15. Kraus T, Pfahlberg A, Gefeller O, Raithel HJ. Respiratory symptoms and diseases among workers in the soft tissue producing industry. Occup Environ Med. 2002;59(12):830-5. doi: 10.1136/oem.59.12.830.
16. Yanamala N, Farcas MT, Hatfield MK, Kisin ER, Kagan VE, Geraci CL, et al. In Vivo Evaluation of the Pulmonary Toxicity of Cellulose Nanocrystals: A Renewable and Sustainable Nanomaterial of the Future. ACS Sustain Chem Eng. 2014;2(7):1691-8. doi: 10.1021/sc500153k.
17. Chen B, Kan H. Air pollution and population health: a global challenge. Environ Health Prev Med. 2008;13(2):94-101. doi: 10.1007/s12199-007-0018-5.
18. Chen Y, Horne SL, Dosman JA. Increased susceptibility to lung dysfunction in female smokers. Am Rev Respir Dis. 1991;143(6):1224-30. doi: 10.1164/ajrccm/143.6.1224.
19. Comstock GW, Meyer MB, Helsing KJ, Tockman MS. Respiratory effects on household exposures to tobacco smoke and gas cooking. Am Rev Respir Dis. 1981;124(2):143-8.
20. Kauffmann F, Becklake M. Maladies obstructives pulmonaires: un paradigme de la complexité des differences de santé entre hommes et femmes. In: Saurel-Cubizolles MJ BB, editor. La santé des femmes. Paris: Flammarion, Medecine et Sciences; 1996. p. 209-33.
21. Schwab R. Sex differences and sleep apnea. Thorax. 1999;54:284-5.
22. Thom TJ. International comparisons in COPD mortality. Am Rev Respir Dis. 1989;140(3 Pt 2):S27-34. doi: 10.1164/ajrccm/140.3_Pt_2.S27.
23. Weinmann GG, Weidenbach-Gerbase M, Foster WM, Zacur H, Frank R. Evidence for ozone-induced small-airway dysfunction: lack of menstrual-cycle and gender effects. Am J Respir Crit Care Med. 1995;152(3):988-96. doi: 10.1164/ajrccm.152.3.7663815.
24. Yanamala N, Hatfield MK, Farcas MT, Schwegler-Berry D, Hummer JA, Shurin MR, et al. Biodiesel versus diesel exposure: enhanced pulmonary inflammation, oxidative stress, and differential morphological changes in the mouse lung. Toxicol Appl Pharmacol. 2013;272(2):373-83. doi: 10.1016/j.taap.2013.07.006
25. Stone KC, Mercer RR, Freeman BA, Chang LY, Crapo JD. Distribution of lung cell numbers and volumes between alveolar and nonalveolar tissue. Am Rev Respir Dis. 1992;146(2):454-6. doi: 10.1164/ajrccm/146.2.454.
26. Mercer RR, Scabilloni J, Wang L, Kisin E, Murray AR, Schwegler-Berry D, et al. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am J Physiol Lung Cell Mol Physiol. 2008;294(1):L87-97. doi: 10.1152/ajplung.00186.2007.
27. ICRP. Human Respiratory Tract Model for Radiological Protection. Ann. ICRP 1994.
28. Reiner RS, Rudie AW. Process scale-up of cellulose nanocrystal production to 25 kg per batch at the forest products laboratory. Production and Applications of Cellulose Nanomaterials. Peachtree Corners, GA: TAPPI Press; 2013.
29. Rao GV, Tinkle S, Weissman DN, Antonini JM, Kashon ML, Salmen R, et al. Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J Toxicol Environ Health A. 2003;66(15):1441-52. doi: 10.1080/15287390306417.
30. Lang JK, Gohil K, Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem. 1986;157(1):106-16.
31. Kerr MK, Churchill GA. Statistical design and the analysis of gene expression microarray data. Genet Res. 2007;89(5-6):509-14. doi: 10.1017/S0016672308009713.
32. Kerr MK, Churchill GA. Statistical design and the analysis of gene expression microarray data. Genet Res. 2001;77(2):123-8.
33. Kerr MK. Design considerations for efficient and effective microarray studies. Biometrics. 2003;59(4):822-8.
34. Team RC. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2015.
35. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002;30(4):e15.
36. Wu H, Kerr MK, Cui X, Churchill G. MAANOVA: A Software Package for the Analysis of Spotted cDNA Microarray Experiments. In: Parmigiani G, Garrett E, Irizarry R, Zeger S, editors. The Analysis of Gene Expression Data. Statistics for Biology and Health. New York: Springer; 2003. p. 313-41.
37. Cui X, Hwang JT, Qiu J, Blades NJ, Churchill GA. Improved statistical tests for differential gene expression by shrinking variance components estimates. Biostatistics. 2005;6(1):59-75. doi: 10.1093/biostatistics/kxh018.
38. Goodnight JH, Harvey WR. Least-Squares Means in the Fixed-Effects General Linear Models. Cary, NC1978 Contract No.: SAS Technical Report R-103.
39. Searle SR, Speed FM, Milliken GA. Population Marginal Means in the Linear Model: An Alternative to Least Squares Means. Am Stat. 1980;34(4):216-21. doi: 10.2307/2684063.
40. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44-57. doi: 10.1038/nprot.2008.211.
41. Huang da W, Sherman BT, Zheng X, Yang J, Imamichi T, Stephens R et al. Extracting biological meaning from large gene lists with DAVID. Current protocols in bioinformatics/editoral board, Andreas D Baxevanis [et al]. 2009;Chapter 13:Unit 13 1. doi: 10.1002/0471250953.bi1311s27.
42. Hu Zhi-Liang BJARJ. CateGOrizer: A Web-Based Program to Batch Analyze Gene Ontology Classification Categories. Online J Bioinform. 2008;9(2):108-12.
43. Supek F, Bosnjak M, Skunca N, Smuc T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One. 2011;6(7):e21800. doi: 10.1371/journal.pone.0021800.
44. Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR, Ma'ayan A. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics. 2010;26(19):2438-44. doi: 10.1093/bioinformatics/btq466.
45. McNally AK, Anderson JM. Macrophage fusion and multinucleated giant cells of inflammation. Adv Exp Med Biol. 2011;713:97-111. doi: 10.1007/978-94-007-0763-4_7.
46. Tatrai E, Brozik M, Adamis Z, Meretey K, Ungvary G. In vivo pulmonary toxicity of cellulose in rats. J Appl Toxicol. 1996;16(2):129-35. doi: 10.1002/(SICI)1099-1263(199603)16:2<129::AID-JAT316>3.0.CO;2-C.
47. Adamis Z, Tatrai E, Honma K, Ungvary G. In vitro and in vivo assessment of the pulmonary toxicity of cellulose. J Appl Toxicol. 1997;17(2):137-41.
48. Hadley J, Kotin P, Bernstein D, editors. Sub-acute (28 days) repeated dose inhalation toxicity of cellulose building insulation in the rat. US Society of Toxicology Conference, Seattle, 11th February; 1992.
49. KF M, A E, A R, C. G. Occupational exposure characterization during the manufacture of cellulose nanomaterials. Production and applications of cellulose nanomaterials. Peachtree Corners, GA: TAPPI Press; 2013.
50. Vartiainen J, Pöhler T, Sirola K, et al. Health and environmental safety aspects of friction grinding and spray drying of microfibrillated cellulose. Cellulose. 2011;18:775-86.
51. Kobayashi H, Kanoh S, Motoyoshi K, Aida S. Diffuse lung disease caused by cotton fibre inhalation but distinct from byssinosis. Thorax. 2004;59(12):1095-7. doi: 10.1136/thx.2003.014027.
52. Greim H, Borm P, Schins R, Donaldson K, Driscoll K, Hartwig A, et al. Toxicity of fibers and particles. Report of the workshop held in Munich, Germany, 26-27 October 2000. Inhal Toxicol. 2001;13(9):737-54. doi: 10.1080/08958370118273.
53. Coplu L, Demir AU, Fuat Kalyoncu A, Coplu N, Selcuk ZT, Enunlu T, et al. Lung health in workers exposed to reed dust. Respir Med. 2005;99(4):421-8. doi: 10.1016/j.rmed.2004.08.015.
54. Kraus T, Pfahlberg A, Zobelein P, Gefeller O, Raithel HJ. Lung function among workers in the soft tissue paper-producing industry. Chest. 2004;125(2):731-6.
55. Stefaniak AB, Seehra MS, Fix NR, Leonard SS. Lung biodurability and free radical production of cellulose nanomaterials. Inhal Toxicol. 2014;26(12):733-49. doi: 10.3109/08958378.2014.948650.
56. CFR. Code of Federal Regulations. Washington, DC: U.S. Government Printing Office, Office of the Federal Register.
57. Bates DV, Fish BR, Hatch TF, Mercer TT, Morrow PE. Deposition and retention models for internal dosimetry of the human respiratory tract. Task group on lung dynamics. Health Phys. 1966;12(2):173-207.
58. [1992] N. Recommendations for occupational safety and health: Compendium of policy documents and statements. In: U.S. Department of Health and Human Services PHS, Centers for Disease Control, National Institute for Occupational Safety and Health, editor. Cincinnati, OH: DHHS (NIOSH); 1992.
59. An J, Ribeiro RC, Webb P, Gustafsson JA, Kushner PJ, Baxter JD, et al. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci U S A. 1999;96(26):15161-6.
60. Hu SK, Mitcho YL, Rath NC. Effect of estradiol on interleukin 1 synthesis by macrophages. Int J Immunopharmacol. 1988;10(3):247-52.
61. Kahlke V, Angele MK, Ayala A, Schwacha MG, Cioffi WG, Bland KI, et al. Immune dysfunction following trauma-haemorrhage: influence of gender and age. Cytokine. 2000;12(1):69-77. doi: 10.1006/cyto.1999.0511.
62. Wichmann MW, Zellweger R, DeMaso CM, Ayala A, Chaudry IH. Enhanced immune responses in females, as opposed to decreased responses in males following haemorrhagic shock and resuscitation. Cytokine. 1996;8(11):853-63. doi: 10.1006/cyto.1996.0114.
63. Kurimoto E, Miyahara N, Kanehiro A, Waseda K, Taniguchi A, Ikeda G, et al. IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice. Respir Res. 2013;14:5. doi: 10.1186/1465-9921-14-5.
64. Kang MJ, Choi JM, Kim BH, Lee CM, Cho WK, Choe G, et al. IL-18 induces emphysema and airway and vascular remodeling via IFN-gamma, IL-17A, and IL-13. Am J Respir Crit Care Med. 2012;185(11):1205-17. doi: 10.1164/rccm.201108-1545OC.
65. Tanaka J, Moriyama H, Terada M, Takada T, Suzuki E, Narita I, et al. An observational study of giant cell interstitial pneumonia and lung fibrosis in hard metal lung disease. BMJ Open. 2014;4(3):e004407. doi: 10.1136/bmjopen-2013-004407.
66. Quinn MT, Schepetkin IA. Role of NADPH oxidase in formation and function of multinucleated giant cells. J Innate Immun. 2009;1(6):509-26. doi: 10.1159/000228158.
67. DeFife KM, Jenney CR, McNally AK, Colton E, Anderson JM. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J Immunol. 1997;158(7):3385-90.
68. McNally AK, DeFife KM, Anderson JM. Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity. Am J Pathol. 1996;149(3):975-85.
69. Linehan SA, Martinez-Pomares L, Gordon S. Mannose receptor and scavenger receptor: two macrophage pattern recognition receptors with diverse functions in tissue homeostasis and host defense. Adv Exp Med Biol. 2000;479:1-14. doi: 10.1007/0-306-46831-x_1.
70. Stahl PD, Ezekowitz RA. The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol. 1998;10(1):50-5.
71. Bleau AM, Maurel P, Pichette V, Leblond F, du Souich P. Interleukin-1beta, interleukin-6, tumour necrosis factor-alpha and interferon-gamma released by a viral infection and an aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytes. Eur J Pharmacol. 2003;473(2-3):197-206.
72. Renton KW. Cytochrome P450 regulation and drug biotransformation during inflammation and infection. Curr Drug Metab. 2004;5(3):235-43.
73. Renton KW. Regulation of drug metabolism and disposition during inflammation and infection. Expert Opin Drug Metab Toxicol. 2005;1(4):629-40. doi: 10.1517/17425255.1.4.629.
74. Aitken AE, Morgan ET. Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes. Drug Metab Dispos. 2007;35(9):1687-93. doi: 10.1124/dmd.107.015511.
75. Teng S, Piquette-Miller M. Regulation of transporters by nuclear hormone receptors: implications during inflammation. Mol Pharm. 2008;5(1):67-76. doi: 10.1021/mp700102q.
76. Siewert E, Bort R, Kluge R, Heinrich PC, Castell J, Jover R. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology. 2000;32(1):49-55. doi: 10.1053/jhep.2000.8532.
77. Warren GW, van Ess PJ, Watson AM, Mattson MP, Blouin RA. Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response. J Interferon Cytokine Res. 2001;21(10):821-6. doi: 10.1089/107999001753238060.
78. Sewer MB, Koop DR, Morgan ET. Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression. J Pharmacol Exp Ther. 1997;280(3):1445-54.
79. Morgan ET. Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev. 1997;29(4):1129-88. doi: 10.3109/03602539709002246.
80. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003;144(8):3382-98. doi: 10.1210/en.2003-0192.
81. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci U S A. 1996;93(18):9776-81.
82. Badawi AF, Cavalieri EL, Rogan EG. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metab Clin Exp. 2001;50(9):1001-3. doi: 10.1053/meta.2001.25592.
83. Leung TM, Nieto N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. J Hepatol. 2013;58(2):395-8. doi: 10.1016/j.jhep.2012.08.018.
84. Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med. 2008;44(5):723-38. doi: 10.1016/j.freeradbiomed.2007.11.004.
85. Cederbaum AI. Nrf2 and antioxidant defense against CYP2E1 toxicity. Subcell Biochem. 2013;67:105-30. doi: 10.1007/978-94-007-5881-0_2.
86. Cederbaum A. Nrf2 and antioxidant defense against CYP2E1 toxicity. Expert Opin Drug Metab Toxicol. 2009;5(10):1223-44. doi: 10.1517/17425250903143769.
87. Prestera T, Holtzclaw WD, Zhang Y, Talalay P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci U S A. 1993;90(7):2965-9.
88. Prestera T, Zhang Y, Spencer SR, Wilczak CA, Talalay P. The electrophile counterattack response: protection against neoplasia and toxicity. Adv Enzym Regul. 1993;33:281-96.
89. Almqvist C, Worm M, Leynaert B, working group of GALENWPG. Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy. 2008;63(1):47-57. doi: 10.1111/j.1398-9995.2007.01524.x.
90. Caracta CF. Gender differences in pulmonary disease. Mt Sinai J Med. 2003;70(4):215-24.
91. Fagan JK, Scheff PA, Hryhorczuk D, Ramakrishnan V, Ross M, Persky V. Prevalence of asthma and other allergic diseases in an adolescent population: association with gender and race. Ann Allergy Asthma Immunol. 2001;86(2):177-84. doi: 10.1016/S1081-1206(10)62688-9.
92. Oiamo TH, Luginaah IN. Extricating sex and gender in air pollution research: a community-based study on cardinal symptoms of exposure. Int J Environ Res Public Health. 2013;10(9):3801-17. doi: 10.3390/ijerph10093801.
93. Riffo-Vasquez Y, Ligeiro de Oliveira AP, Page CP, Spina D, Tavares-de-Lima W. Role of sex hormones in allergic inflammation in mice. Clin Exp Allergy. 2007;37(3):459-70. doi: 10.1111/j.1365-2222.2007.02670.x.
94. Casimir GJ, Lefevre N, Corazza F, Duchateau J. Sex and inflammation in respiratory diseases: a clinical viewpoint. Biol Sex Differ. 2013;4:16. doi: 10.1186/2042-6410-4-16.
95. Morrissey BM, Harper RW. Bronchiectasis: sex and gender considerations. Clin Chest Med. 2004;25(2):361-72. doi: 10.1016/j.ccm.2004.01.011.
96. Bonds RS, Midoro-Horiuti T. Estrogen effects in allergy and asthma. Curr Opin Allergy Clin Immunol. 2013;13(1):92-9. doi: 10.1097/ACI.0b013e32835a6dd6.
97. Haggerty CL, Ness RB, Kelsey S, Waterer GW. The impact of estrogen and progesterone on asthma. Ann Allergy Asthma Immunol. 2003;90(3):284-91. doi: 10.1016/S1081-1206(10)61794-2. quiz 91-3, 347.
98. Simpson ER, Clyne C, Rubin G, Boon WC, Robertson K, Britt K, et al. Aromatase--a brief overview. Annu Rev Physiol. 2002;64:93-127. doi: 10.1146/annurev.physiol.64.081601.142703.
99. Tsuchiya Y, Nakajima M, Kyo S, Kanaya T, Inoue M, Yokoi T. Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res. 2004;64(9):3119-25.
100. Tam A, Morrish D, Wadsworth S, Dorscheid D, Man SF, Sin DD. The role of female hormones on lung function in chronic lung diseases. BMC Womens Health. 2011;11:24. doi: 10.1186/1472-6874-11-24.
101. Keselman A, Heller NM. Estrogen signaling modulates allergic inflammation and contributes to sex differences in asthma. Front Immunol. 2015;6. doi: 10.3389/fimmu.2015.00568.
102. Cutolo M, Sulli A, Straub RH. Estrogen's effects in chronic autoimmune/inflammatory diseases and progression to cancer. Expert Rev Clin Immunol. 2014;10(1):31-9. doi: 10.1586/1744666X.2014.863149.
103. Cai Y, Zhou J, Webb DC. Estrogen stimulates Th2 cytokine production and regulates the compartmentalisation of eosinophils during allergen challenge in a mouse model of asthma. Int Arch Allergy Immunol. 2012;158(3):252-60. doi: 10.1159/000331437.
104. Carey MA, Card JW, Voltz JW, Germolec DR, Korach KS, Zeldin DC. The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol Lung Cell Mol Physiol. 2007;293(2):L272-8. doi: 10.1152/ajplung.00174.2007.
105. Robbe P, Draijer C, Borg TR, Luinge M, Timens W, Wouters IM, et al. Distinct macrophage phenotypes in allergic and nonallergic lung inflammation. Am J Physiol Lung Cell Mol Physiol. 2015;308(4):L358-67. doi: 10.1152/ajplung.00341.2014.
106. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323(15):1033-9. doi: 10.1056/NEJM199010113231505.
107. Liu YC, Zou XB, Chai YF, Yao YM. Macrophage polarization in inflammatory diseases. Int J Biol Sci. 2014;10(5):520-9. doi: 10.7150/ijbs.8879.
108. Labonte AC, Tosello-Trampont AC, Hahn YS. The role of macrophage polarization in infectious and inflammatory diseases. Mol Cells. 2014;37(4):275-85. doi: 10.14348/molcells.2014.2374.
109. Clougherty JE, Eisen EA, Slade MD, Kawachi I, Cullen MR. Gender and sex differences in job status and hypertension. Occup Environ Med. 2011;68(1):16-23. doi: 10.1136/oem.2009.049908.
110. Clougherty JE. A growing role for gender analysis in air pollution epidemiology. Environ Health Perspect. 2010;118(2):167-76. doi: 10.1289/ehp.0900994.